1-5 of 5
Yvette Neme Yunes
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Real-World Overall Response Rate (ORR) of Diffuse Large B-Cell Lymphoma with Polatuzumab Vedotin-Based Theraphy, a Multicentric Study in Mexico

SilviaMargarita RodriguezMejorada, Alberto Villalobos Prieto, Adrían Alejandro Ceballos López, Eduardo Edmundo Reynoso Gomez, Celia Carela Sandoval Villa, Francisco Jose Tripp Villanueva, Diego Cruz Contreras, Alicia Elizabeth Guzman Hernandez, Omar Genaro Lopez Navarro, Yvette Neme Yunes, Oscar De Jesus Perez Ramirez, Enrique Rico Curiel, Diego Mauricio Barbosa Loria
Journal: Blood
Blood (2023) 142 (Supplement 1): 7404.
https://doi.org/10.1182/blood-2023-189945
Published: 2023
Journal Articles

Effectiveness and Security of a Modified CALGB10403 in Adolescents and Young Adults with Acute Lymphoblastic Leukemia in Low-and-Middle-Income Countries: A Multicentric Experience in Central America

Juan Rangel-Patiño, Lee-Tsai Yu Ling, Victor Itaí Urbalejo Ceniceros, Maria Elena Monserrat Luna Perez, Karla Adriana Espinosa, Lauro Fabian Amador, Alvaro Cabrero Garcia, Carolina Balderas-Delgado, Sergio I Inclan-Alarcon, Yvette Neme Yunes, Luis Meillon-García, Jose Manuel Sanchez Albarran, Elia Ixel Apodaca, Roberta Demichelis
Journal: Blood
Blood (2021) 138 (Supplement 1): 2284.
https://doi.org/10.1182/blood-2021-153545
Published: 2021
Journal Articles

A Modified CALGB-10403 in Hispanic Adolescent and Young Adults with Philadelphia -Negative Acute Lymphoblastic Leukemia: Promising Results Despite a High-Rate of Metabolic and Hepatic Toxicities

Juan Rangel-Patiño, MD, Alvaro Cabrero Garcia, Carolina Balderas-Delgado, MD, Lauro Fabian Amador, MD, Yvette Neme Yunes, Ana Cooke, MD, Adriana Rosas, Roberta Demichelis, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1352.
https://doi.org/10.1182/blood-2019-126108
Published: 2019
Journal Articles

CMV Reactivations and Their Impact On Outcomes in Patients After Hematopoietic Cell Transplantation

Naheed Alam, MBBS, Anna Lambie, NP, Yvette Neme Yunes, MD, Feras Alfraih, MD, Eshetu G Atenafu, MSc, Dennis Dong Hwan Kim, MD, PhD, Vikas Gupta, MD, FRCP, FRCPath, John Kuruvilla, MD, Jeff H Lipton, MD, Hans A. Messner, M.D./Ph.D
Journal: Blood
Blood (2012) 120 (21): 4501.
https://doi.org/10.1182/blood.V120.21.4501.4501
Published: 2012
Journal Articles

An Alternative Method for Myeloablative Allogenic Stem Cell Transplantation in Hematological Malignancies: Reduced BUCY2 and GCS-F Primed Bone Marrow Stem Cells

Eucario León-Rodríguez, MD, Patricia Guzmán-Uribe, MD, Sandra Ileana Pérez-Álvarez, MD, Andrea Castro-Sánchez, MD, Karla Adriana Espinosa-Bautista, MD, Alejandra Armengol-Alonso, MD, Elena Tuna-Aguilar, MD, Yvette Neme-Yunes, MD, Irma Espinosa-Poblano, MD, Antonio Velázquez-González, MD
Journal: Blood
Blood (2012) 120 (21): 4138.
https://doi.org/10.1182/blood.V120.21.4138.4138
Published: 2012